Antonia Rotolo

848 total citations
29 papers, 395 citations indexed

About

Antonia Rotolo is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Antonia Rotolo has authored 29 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Antonia Rotolo's work include CAR-T cell therapy research (12 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Antonia Rotolo is often cited by papers focused on CAR-T cell therapy research (12 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Antonia Rotolo collaborates with scholars based in United States, Italy and United Kingdom. Antonia Rotolo's co-authors include Anastasios Karadimitris, Valentina S. Caputo, John Maher, Mohammed S. Chaudhry, Monika Holubová, Olivier Dubois, Kikkeri N. Naresh, Nicola J. Mason, Katerina Goudevenou and Xiaolin Xiao and has published in prestigious journals such as Blood, Cancer Cell and Cancer Research.

In The Last Decade

Antonia Rotolo

25 papers receiving 391 citations

Peers

Antonia Rotolo
Elizabeth Veloso United States
Jine Zheng China
Antonio Valeri Spain
Samuel John United States
Serena Scala Italy
Anniek B. van der Waart Netherlands
Naomi Porret Switzerland
Haitham Abdelhakim United States
Sibgha Gull Chaudhary United States
Wenhong Shen China
Elizabeth Veloso United States
Antonia Rotolo
Citations per year, relative to Antonia Rotolo Antonia Rotolo (= 1×) peers Elizabeth Veloso

Countries citing papers authored by Antonia Rotolo

Since Specialization
Citations

This map shows the geographic impact of Antonia Rotolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonia Rotolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonia Rotolo more than expected).

Fields of papers citing papers by Antonia Rotolo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonia Rotolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonia Rotolo. The network helps show where Antonia Rotolo may publish in the future.

Co-authorship network of co-authors of Antonia Rotolo

This figure shows the co-authorship network connecting the top 25 collaborators of Antonia Rotolo. A scholar is included among the top collaborators of Antonia Rotolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonia Rotolo. Antonia Rotolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swain, J. E., Jonathan Sussman, Fan Yang, et al.. (2025). Single-cell multiomic comparison of mouse and rat spermatogenesis reveals gene regulatory networks conserved for over 20 million years. Stem Cell Reports. 20(4). 102449–102449.
2.
Rotolo, Antonia, Nicola J. Mason, & Mark A. Exley. (2025). Innate iNKT cells: from biological insight to clinical impact. Frontiers in Immunology. 16. 1653183–1653183.
3.
Rotolo, Antonia, et al.. (2024). Validation of a PD-1/CD28 chimeric switch receptor to augment CAR-T function in dogs with spontaneous B cell lymphoma. iScience. 27(9). 110863–110863. 2 indexed citations
4.
Rotolo, Antonia & Matthew J. Atherton. (2024). Applications and Opportunities for Immune Cell CAR Engineering in Comparative Oncology. Clinical Cancer Research. 30(11). 2359–2369. 2 indexed citations
5.
Cheng, Keren, Yasunari Seita, Young Sun Hwang, et al.. (2024). Defining the cellular origin of seminoma by transcriptional and epigenetic mapping to the normal human germline. Cell Reports. 43(6). 114323–114323. 4 indexed citations
6.
Kuramitsu, Shunichiro, Tong Da, Sangya Agarwal, et al.. (2023). Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma. Blood Advances. 7(14). 3416–3430. 27 indexed citations
7.
Rotolo, Antonia, Matthew J. Atherton, Irina Kulikovskaya, et al.. (2023). Unedited allogeneic iNKT cells show extended persistence in MHC-mismatched canine recipients. Cell Reports Medicine. 4(10). 101241–101241. 13 indexed citations
8.
Angelos, Mathew G., Wei Xie, Raymone Pajarillo, et al.. (2023). Fratricide-Resistant Anti-CD2 Chimeric Antigen Receptor T-Cells with Endogenous CD2 Knockout Are Highly Effective Against T-Cell Neoplasms. Blood. 142(Supplement 1). 885–885. 3 indexed citations
9.
Atherton, Matthew J., Antonia Rotolo, Kumudhini Preethi Haran, & Nicola J. Mason. (2022). Case Report: Clinical and Serological Hallmarks of Cytokine Release Syndrome in a Canine B Cell Lymphoma Patient Treated With Autologous CAR-T Cells. Frontiers in Veterinary Science. 9. 824982–824982. 7 indexed citations
10.
Rotolo, Antonia, Matthew J. Atherton, Brian Kasper, Kumudhini Preethi Haran, & Nicola J. Mason. (2021). Genetic re-direction of canine primary T cells for clinical trial use in pet dogs with spontaneous cancer. STAR Protocols. 2(4). 100905–100905. 15 indexed citations
11.
Mason, Nicola J., Nicholas Chester, Ailian Xiong, et al.. (2021). Development of a fully canine anti-canine CTLA4 monoclonal antibody for comparative translational research in dogs with spontaneous tumors. mAbs. 13(1). 2004638–2004638. 24 indexed citations
12.
Rotolo, Antonia, Valentina S. Caputo, Monika Holubová, et al.. (2018). Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting. Cancer Cell. 34(4). 596–610.e11. 132 indexed citations
13.
Marín, David, Antonia Rotolo, Dragana Milojković, & John M. Goldman. (2013). The next questions in chronic myeloid leukaemia and their answers. Current Opinion in Hematology. 20(2). 163–168. 6 indexed citations
14.
Cilloni, Daniela, Emanuela Messa, Antonia Rotolo, & Giuseppe Saglio. (2010). Emerging drugs for chronic myeloid leukemia. Expert Opinion on Emerging Drugs. 15(2). 175–184. 3 indexed citations
15.
16.
Arruga, Francesca, Francesca Messa, Monica Pradotto, et al.. (2010). Abstract 251: Disabled gene is involved in CML progression and its expression level at diagnosis can predict major molecular response (MMR) to imatinib therapy. Cancer Research. 70(8_Supplement). 251–251. 1 indexed citations
17.
Cilloni, Daniela, Francesca Arruga, Francesca Messa, et al.. (2009). Disabled Gene Is Involved in CML Progression and Its Expression Level at Diagnosis Can Predict Major Molecular Response (MMR) to Imatinib Therapy.. Blood. 114(22). 3964–3964. 1 indexed citations
18.
Defilippi, Ilaria, Sonia Carturan, Antonella Roetto, et al.. (2008). Detection of Humoral Immune Responses against WT1 Antigen in Patients Affected by Different Hematological Malignancies. Acta Haematologica. 120(1). 47–50. 1 indexed citations
19.
Ferranti, Francesca, et al.. (1996). [Leiomyosarcoma of the mesentery. A case report and clinico-diagnostic considerations].. PubMed. 51(12). 1111–5. 1 indexed citations
20.
Cotellese, Roberto, et al.. (1987). [Primary closure of the residual cavity after abdominoperineal amputation of the rectum].. PubMed. 42(5). 365–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Veloso Breakdown of academic impact, for papers by Jine Zheng Breakdown of academic impact, for papers by Antonio Valeri Breakdown of academic impact, for papers by Samuel John Breakdown of academic impact, for papers by Serena Scala Breakdown of academic impact, for papers by Anniek B. van der Waart Breakdown of academic impact, for papers by Naomi Porret Breakdown of academic impact, for papers by Haitham Abdelhakim Breakdown of academic impact, for papers by Sibgha Gull Chaudhary Breakdown of academic impact, for papers by Wenhong Shen
Rankless by CCL
2026